Mycophenolate mofetil (MMF) versus azathioprine (AZA) in a large registry of pediatric renal transplant patients.

被引：0
|
作者：
Steffen, B
Gotz, V
Chu, A
Gordon, R
Morris, J
机构：
[1] Roche Labs Inc, Nutley, NJ USA
[2] ProSanos Corp, Analyt, La Jolla, CA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：651A / 651A
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics of Mycophenolate Mofetil in Pediatric Liver Transplant Recipients to Optimize MMF Dose
    Barau, C.
    Habes, D.
    Debray, D.
    Taburet, A. M.
    Furlan, V.
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 651 - 652
  • [32] Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant recipients
    Montanaro, D
    Gropuzzo, M
    Tulissi, P
    Boscutti, G
    Risaliti, A
    Baccarani, U
    Sainz, M
    Mioni, G
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3253 - 3255
  • [33] Azathioprine vs. mycophenolate mofetil in geriatric renal transplant recipients
    Meier-Kriesche, HU
    Jacobs, M
    Mulgaonkar, S
    Friedman, G
    Vaghela, M
    Thambuganipalle, R
    Haq, N
    Kaplan, B
    TRANSPLANTATION, 1999, 67 (07) : S233 - S233
  • [34] Long-term effects of the conversion from azathioprine (AZA) to mycophenolate mofetil (MMF) in patients with chronic allograft dysfunction (CAD).
    Alves, EC
    Felipe, CR
    Park, SI
    Silva, LA
    Machado, PG
    Garcia, R
    Tedesco-Silva, H
    Medina-Pestana, JO
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 220 - 220
  • [35] Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: An analysis of the joint UNOS/ISHLT thoracic registry
    Hosenpud, JD
    Bennett, LE
    TRANSPLANTATION, 2001, 72 (10) : 1662 - 1665
  • [36] The efficacy and safety of mycophenolate mofetil (MMF) in the treatment of acute and chronic GVHD in bone marrow transplant patients.
    Basara, N
    Blau, W
    Kiehl, MG
    Romer, E
    Rudolphi, M
    Bischoff, M
    Kirsten, D
    Sanchez, H
    Gunzelmann, S
    Fauser, AA
    BONE MARROW TRANSPLANTATION, 1998, 21 : S117 - S117
  • [37] Mycophenolate mofetil and bronchiectasis in pediatric transplant patients
    Merkus, Peter J. F. M.
    Pijnenburg, Marielle
    Cransberg, Karlien
    TRANSPLANTATION, 2006, 82 (10) : 1386 - 1386
  • [38] Sequential determination of pharmacokinetics (PK) and pharmacodynamics (PD) of mycophenolate mofetil (MMF) in liver transplant (LT) patients.
    Brunet, M
    Martorell, J
    Vidal, E
    Jimenez, O
    Millan, O
    Rojo, I
    Cirera, I
    Rimola, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 528 - 529
  • [39] Immunosuppressive properties of mycophenolate mofetil and valganciclovir used in combination in renal transplant patients.
    Bearden, CM
    Book, BK
    Sidner, RA
    Pescovitz, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 565 - 565
  • [40] A randomized, double-blind comparative study of mycophenolate mofetil (MMF) and azathioprine (AZA),in combination with cyclosporine and corticosteroids in liver transplant recipients.
    Mamelok, RD
    Kalayoglu, M
    Klintmalm, G
    Langnas, AN
    Levy, GA
    McDiarmid, SV
    McMaster, P
    Merion, R
    Rabkin, JM
    Wang, WD
    Wiesner, RH
    HEPATOLOGY, 1999, 30 (04) : 222A - 222A
12345